mPEG Cysteine - MW 2000 Da

Cat. No.: m163985
Zu bestellen verfügbar
QUALITÄT & REINHEIT MW 2000 Da
Storage
Room temperature
Shipped In
Normal
★
Größe
Deutschland (EU)
USA*
Preis
Menge
100mg
m163985-100mg
—
3 Auf Lager
28,55€
500mg
m163985-500mg
—
2 Auf Lager
101,44€
Enter a quantity for the sizes you want to add.

Übersicht

Nanocs' amino acid and peptide PEG conjugates were made from the covalent attachment of PEG to various amino acid derivatives. Conjugates were provided in lyophilized powder form.

Spezifikationen

Spezifikationen & Reinheit
MW 2000 Da
Storage
Room temperature
Verschickt in
Normal

Erweiterte Daten

Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

1 results found

Lot NumberCertificate TypeDatumArtikel
D1825025D1825025Certificate of AnalysisMar 08, 2024 m163985
Chemische und physikalische Eigenschaften
LöslichkeitLyophilized powder form;Soluble in regular aqeous solution and common organic solvents;
FAQs und Artikel
Lösungsrechner
Bewertungen

Kundenbewertungen

Application Protocols

No vendor-validated application protocols are specified for this SKU. The following generic workflow outlines are literature-based suggestions and must be optimized by the user:

  • Maleimide coupling (general):
    1. Prepare target maleimide-functional substrate in degassed PBS (pH 6.8–7.0).
    2. Dissolve mPEG Cysteine in the same buffer (1–10 mM). If needed, pre-reduce with 1–5 mM TCEP for 15–30 min, then remove TCEP by desalting.
    3. Mix at 1.2 eq mPEG-Cys per maleimide; incubate 1–2 h at room temp.
    4. Quench unreacted maleimide with cysteine or mercaptoethanol; purify by SEC/diafiltration.
  • Disulfide exchange:
    1. React mPEG Cys with pyridyl disulfide substrates in phosphate buffer (pH ~7.2).
    2. Monitor A343 for 2-thiopyridone release; stop when plateaued; purify.
  • Amide coupling via –CO2H:
    1. Activate with EDC/NHS in MES (pH 5.5), 10–30 min on ice.
    2. Add amine-bearing partner in pH 7.8–8.3 buffer; incubate 1–4 h; purify. These are general templates; adjust concentrations/stoichiometry based on polymer Mn and partner reactivity. No claims of performance are made for SKU m163985.
Biological Roles

Item-specific biological/clinical roles are not claimed. The following notes are general, literature-based context for the components:

  • Poly(ethylene glycol) (PEG): Considered biologically inert and non-ionic; it increases hydrodynamic radius, reduces non-specific interactions, and improves solubility of conjugated cargos (proteins, peptides, small molecules). PEGylation can reduce proteolysis and aggregation in vitro and modulate surface properties of nanoparticles.
  • Cysteine: A sulfur-containing amino acid with a thiol side chain; in proteins it forms disulfide bonds and serves as a nucleophile in active sites. As an end-group, cysteine enables chemoselective conjugation via the thiol, while the α-amine/carboxyl can be exploited for orthogonal coupling or charge tuning.
  • Zwitterionic behavior: At neutral pH, free cysteine typically exists as a zwitterion (–NH3+ and –COO−). Attachment to PEG may subtly affect local pKa and reactivity but generally retains nucleophilicity of the thiolate under mildly basic conditions.
  • Biomolecular interfacing: mPEG Cysteine can be used to tailor surfaces/biomolecules in research to reduce fouling while introducing a reactive thiol handle for selective attachment to maleimide or gold surfaces (Au–S affinity), enabling model systems in biophysics and materials science. These roles are general background and not specific performance claims for SKU m163985.
Buffer Applications

Not a conventional buffering agent. While the cysteine end group possesses acid/base functionality (amine/carboxyl) that can influence local pH in concentrated solutions, mPEG Cysteine is not typically used to establish or maintain buffer capacity.

Practical guidance (literature/general):

  • Choose established buffer systems (phosphate, HEPES, MOPS) for bioconjugation with mPEG Cysteine. Maintain pH ~6.5–7.2 for maleimide–thiol coupling to balance thiol reactivity and maleimide stability.
  • Avoid primary amine buffers (e.g., Tris) during EDC/NHS activation or when targeting amine-reactive partners, as they compete and quench activated esters.
  • Degas buffers and include 0.1–1 mM TCEP when preserving free thiol prior to coupling; remove reducing agent before addition to maleimide substrates (e.g., by desalting columns). All details above are general literature recommendations; no item-specific buffer formulation is provided for this SKU.
Green Alternatives

Context: PEG-based reagents are often considered relatively benign due to low volatility, low flammability, and favorable EHS profiles compared to many organic solvents/reagents. However, lifecycle considerations (ethylene oxide origin, polymer processing) and aquatic persistence should be weighed.

Greener choices and trade-offs (literature, general):

  • Polyglycerol (PG) derivatives: Renewable feedstock, highly hydrophilic, branched architectures can reduce viscosity and enhance stability. Trade-off: Different hydrodynamic radii and conjugation chemistries vs PEG; immunogenicity profiles may differ.
  • Poly(2-oxazoline)s (PAOx): Tunable hydrophilicity, good bioconjugation profiles; synthetic complexity higher than PEG; less long-term biocompatibility history.
  • mPEG–thiol vs mPEG Cysteine: If only thiol functionality is needed, mPEG–thiol removes amino/carboxyl reactivity, simplifying buffers and reducing side reactions (greener via fewer reagents/steps). Trade-off: Loss of orthogonality provided by amine/carboxyl.

Mini-comparison (general):

  • PEG: Widely validated, excellent aqueous solubility, simple analytics; petroleum-derived; potential for oxidative degradation over time.
  • PG: Renewable, high hydroxyl functionality, good biodegradability; different coupling toolkits required.
  • PAOx: Precise architectures, potential improved stability; more specialized monomers and synthesis. Selection should consider solvent reduction (do in water), minimizing protecting-group chemistry, and using catalytic/orthogonal, aqueous coupling strategies (e.g., maleimide–thiol at near-neutral pH).
Pharmaceutical Uses

No pharmacopeial status, excipient designation, or clinical application claims are provided for this item. The following are general, non-clinical notes on how similar materials are used in research and development contexts:

  • Conjugation scaffold: mPEG cysteine can serve as a research-grade PEGylation reagent to modify peptides, enzymes, or drug-like molecules via thiol chemistry, improving aqueous handling and reducing non-specific adsorption in in vitro studies.
  • Surface modification: Provides an antifouling PEG layer while retaining a thiol for attachment to maleimide-functional polymers, nanoparticles, or gold surfaces in formulation development and device prototyping.
  • Pre-formulation screening: Used to explore PEG length and end-group impacts on solubility, viscosity, and stability of candidate biomolecules. The cysteine’s amine/carboxyl groups enable further derivatization routes in screening libraries.
  • Reference testing: Employed to benchmark analytical methods (SEC, DLS, HIC) for PEGylated species. Any regulated or clinical use would require appropriate grade, specifications, and regulatory review; this SKU is labeled For research use only.
Physical Properties

Item-specific physical constants (BP, MP, density, exact solubility, logP, pKa, refractive index) are not specified for this item; refer to CoA/Spec Sheet.

General properties of mPEG-cysteine materials (literature, non-item-specific):

  • Physical state: PEGs are typically colorless to white, ranging from viscous liquids to waxy/solid depending on molecular weight (Mn). Cysteine termination usually has minimal impact on gross physical state for the same Mn.
  • Solubility: highly soluble/miscible in water and many polar organics (MeOH, EtOH, DMSO, DMF). Solubility in nonpolar solvents is poor to moderate, improving with higher PEG length and reduced ionic character (e.g., if cysteine is protected or present as zwitterion at neutral pH).
  • Hygroscopicity: PEGs are hygroscopic and readily absorb moisture; aqueous solutions are stable over a broad pH range but thiols can oxidize.
  • pKa values (literature, for free cysteine end group): thiol pKa ~8.3–8.6; α-ammonium pKa ~9–10; α-carboxyl pKa ~2.0; actual apparent pKa can shift due to microenvironment and polymer attachment.
  • Viscosity: increases strongly with Mn and concentration; affects handling and transfer.
  • Thermal behavior: PEG glass transition around −60 to −40 °C; softening/melting temperature increases with Mn (e.g., PEG200 solidifies below room temp; higher Mn are waxy solids), but specific values depend on exact Mn and polydispersity. All numeric values above are literature expectations and not specifications for this SKU.
Quality and Grades

Item-specific grade/purity and appearance are not specified for this item; refer to CoA/Spec Sheet.

General notes for mPEG-cysteine materials:

  • Polymer specifications: Quality is typically defined by number-average molecular weight (Mn), polydispersity index (Ð), and end-group fidelity (functionality >95–98%). SEC/GPC with multiangle light scattering and 1H NMR are standard.
  • Functional titer: For thiol-terminated materials, quantification by Ellman’s (DTNB) assay provides the free –SH content. For cysteine-terminated products, both free amine and carboxyl content may be assessed by titration or derivatization.
  • Residuals: Solvent and salt content (e.g., water, DMF, DMSO, inorganic salts) and metal residues may be controlled in high-purity/bioconjugation grades. For HPLC/bioconjugation-grade PEGs, low UV background and low endotoxin are often targeted; specific limits are Not specified for this item; refer to CoA/Spec Sheet.
  • Stabilizers: PEGs typically do not require stabilizers; thiol-containing products may be supplied under inert atmosphere or with reducing agents/antioxidants in some offerings (not specified here). Any stabilizer presence should be verified on the CoA.
  • Documentation: For regulated workflows, suppliers provide CoA, TSE/BSE statements, and, where applicable, residual solvent and elemental impurity data. Confirm item-specific documentation for SKU m163985 prior to critical use.
Reaction and Applications

This reagent is typically used as a PEGylation handle enabling site-selective conjugation through cysteine chemistry while leveraging PEG’s solubilizing and stealth properties. Item-specific application claims are not provided; the following are literature/general uses.

Representative applications:

  • Maleimide–thiol coupling: Rapid Michael addition at pH ~6.5–7.2 to maleimide-activated biomolecules/surfaces. Minimizes hydrolysis/side reactions. Maintain degassed buffers; perform under inert gas.
  • Haloacetyl/iodoacetamide coupling: Alkylation of cysteine –SH at pH 7.5–8.5. Use excess base and avoid competing thiols.
  • Disulfide exchange: Reaction with activated disulfides (e.g., pyridyl disulfide) at neutral pH to form reversible linkages; track by 2-thiopyridone release (343 nm).
  • Amide coupling (via carboxyl of cysteine): EDC/NHS or HATU-mediated coupling to amines on surfaces or ligands. Avoid Tris or other nucleophilic buffers during activation.
  • Thiol–ene/thiol–yne: Radical-mediated additions to alkenes/alkynes (UV/thermal initiators) on polymers or nanoparticles.

Practical tips:

  • Preserve thiol: Use TCEP (non-thiol reducing agent) in small excess; remove before maleimide reactions. Avoid DTT/β-mercaptoethanol in final coupling as they compete for maleimide.
  • Stoichiometry: For monofunctional mPEG-Cys, use 1.1–2.0 eq to target reactive partner for high conversion while controlling over-PEGylation.
  • Analytics: Confirm conjugation by SEC, SDS-PAGE shift (for proteins), MALDI/ESI (when Mn allows), Ellman’s assay (pre-/post-coupling), and UV monitoring for leaving groups.
Reaction Conditions

Item-specific optimal conditions are not provided. Below are general, literature-based conditions for common transformations involving cysteine termini:

  • Maleimide–thiol coupling: Buffer pH 6.5–7.2, 20–25 °C, 0.5–2 h; molar ratios 1.1–1.5 eq mPEG-Cys per maleimide. Degas buffers; exclude thiol-based reductants during coupling. Typical conversions >90% under clean conditions.
  • Haloacetyl (e.g., iodoacetamide) alkylation: pH 7.5–8.5, 20–25 °C, 1–4 h; add base (e.g., NaHCO3) and limit competing nucleophiles. Monitor to avoid overalkylation of amines at higher pH.
  • Disulfide exchange (with pyridyl disulfides): pH 7.0–7.5, 20–25 °C, 0.5–3 h; monitor release of 2-thiopyridone at 343 nm.
  • Amide coupling via carboxyl (EDC/NHS): Activate at pH 5.0–6.0 (MES buffer), then couple to amines at pH 7.5–8.5; 0–25 °C, 1–12 h. Avoid primary amine buffers.
  • Thiol–ene click: Radical initiator (AIBN or photoinitiator), solvent DMSO/DMF or aqueous-organic mixtures, 25–60 °C or UV (365 nm), 0.5–4 h.

Workup/analytics:

  • Desalt or diafilter to remove small-molecule byproducts; verify by SEC/MALS, 1H NMR, and Ellman’s assay (pre-/post- reaction) when free thiol quantitation is relevant. All conditions are general guidance only and should be optimized for the specific counterpart and polymer Mn.
Safety and Handling

Item-specific hazard classification, signal word, H-statements, and pictograms: Not specified for this item; refer to the SDS for authoritative safety information.

General safety guidance (literature/best practice):

  • Likely low acute toxicity typical of PEG derivatives, but cysteine thiol functionality can oxidize and, in some cases, emit mild sulfurous odor; avoid inhalation of dust/aerosols and skin/eye contact.
  • PPE: laboratory coat, safety glasses, nitrile gloves. Use in a fume hood when weighing powders or preparing solutions, especially if using volatile organic solvents.
  • Incompatibilities: strong oxidizers (thiol oxidation to disulfides); strong bases/acids may induce amidation/ester hydrolysis if linkers are present and can alter thiol/amine ionization. Metals and air can catalyze thiol oxidation.
  • Special risks: thiol groups can form disulfides upon air exposure; maintain reducing conditions (e.g., argon/nitrogen headspace, add TCEP/DTT when appropriate) to preserve free –SH functionality.
  • First aid (overview): rinse eyes/skin with water for 15 minutes if contacted; remove contaminated clothing; if inhaled, move to fresh air; if ingested, rinse mouth. Seek medical evaluation as per SDS instructions.
  • Spill/cleanup: collect solids with minimal dust; absorb solutions with inert material; wash area with water/detergent. Dispose according to local regulations and SDS.
Solvent Selection

Applicability: mPEG Cysteine is a polar, water-compatible polymeric reagent. Solvent choice depends on the desired ionization state of the cysteine and the coupling chemistry.

General solvent guidance (literature):

  • Aqueous buffers: Highly suitable for bioconjugation; use degassed buffers to minimize thiol oxidation. Typical systems: PBS (pH 6.8–7.4), phosphate-borate for broader pH, or HEPES. Avoid primary amine buffers (e.g., Tris) for amide-coupling steps as they compete with nucleophiles.
  • Organic/water-miscible: DMSO, DMF, NMP, and methanol/ethanol can dissolve higher-Mn PEGs; co-solvent approaches (10–50% v/v) help maintain solubility of proteins/biomolecules during conjugation.
  • Nonpolar media: Generally poor solubility; if required, use minimal amounts or switch to protected/activated variants that improve organic solubility.
  • pH influence: The cysteine thiol (pKa ~8.3–8.6) is more nucleophilic above neutral pH, but higher pH accelerates oxidation; balance reactivity with stability and substrate compatibility.

When to choose vs alternatives:

  • Choose mPEG Cysteine when a single-point PEGylation through thiol chemistry (maleimide, haloacetyl, disulfide exchange) is desired, while retaining the amine/carboxyl handles for orthogonal strategies.
  • Consider mPEG–thiol (–SH only) if you need exclusive thiol functionality without amine/carboxyl reactivity; consider mPEG–amine or mPEG–carboxyl for amide coupling in strictly aqueous buffers without thiol management.
Storage and Reconstitution

Item-specific storage: Room temperature (per product data). Shipped under normal conditions.

Additional handling guidance (general best practice, not item-specific specifications):

  • Protect from moisture: PEGs are hygroscopic; store tightly closed in a desiccator or with desiccant. Minimize air exposure to preserve free thiol.
  • Oxygen/light: To conserve cysteine –SH, consider storing under inert gas (N2/Ar) and away from light to reduce oxidation. If long-term storage is planned, refrigeration (2–8 °C) can slow oxidation, provided the item’s CoA does not advise otherwise.
  • Reconstitution: Dissolve in degassed water or appropriate buffer/solvent (e.g., PBS, HEPES, DMSO, DMF) to the desired concentration. For free-thiol applications, include 0.1–1 mM TCEP during short-term holding, then remove before maleimide coupling.
  • Solution stability: Aqueous solutions are generally stable for hours to days at neutral pH if oxygen is excluded; monitor for disulfide formation (loss of free –SH by Ellman’s test). Prepare fresh solutions for critical conjugations.
  • Freeze–thaw: If storing solutions, aliquot to avoid repeated freeze–thaw cycles that may promote oxidation or contamination. For definitive item-specific storage limits, shelf life, and stabilizers (if any), refer to the product CoA/Spec Sheet and SDS. The product is labeled For research use only.
Structure and Identity

Item-specific identifiers provided: SKU m163985; Product name mPEG Cysteine. No CAS, SMILES, InChIKey, molecular formula, or exact molecular weight are specified for this item; refer to CoA/Spec Sheet.

General description (literature):

  • mPEG Cysteine typically denotes a methoxy-terminated poly(ethylene glycol) (mPEG) polymer chain bearing a single terminal L-cysteine residue. The polymer end-grouping is: CH3–O–(CH2–CH2–O)n–(linker, if any)–Cys.
  • Key functional groups/features: a polyether backbone (PEG), and a cysteine moiety presenting a thiol (–SH), a primary amine (–NH2), and a carboxylic acid (–CO2H). Depending on protecting/activation state (not specified here), the cysteine may be free or protected/activated in commercial variants.
  • Structural motif (2D verbal): a flexible PEG chain of repeating ethylene oxide units ending in a methoxy cap at one terminus and a cysteine side chain (–CH2–SH) plus α-amino/α-carboxylate at the other.
  • Stereochemistry: cysteine is chiral (L-configuration in biological form). Unless otherwise noted for a specific SKU, the stereochemistry and protecting group state are not specified for this item; refer to CoA/Spec Sheet.
  • Typical identity tests (literature): 1H/13C NMR showing PEG methylene envelope (~3.65 ppm), methoxy singlet (~3.35 ppm), and cysteine resonances; SEC/GPC for Mn/Mw; FTIR with strong C–O–C stretches (~1100 cm−1); Ellman’s assay for free thiol content when applicable.
Synthetic Utility

mPEG Cysteine functions as a monofunctional polymeric building block and linker, offering a versatile combination of PEG solubilization and cysteine reactivity.

Key functional handles (general):

  • Thiol (–SH): Nucleophilic conjugation to maleimides, vinyl sulfones, haloacetyls; metal-surface chemisorption (Au–S); oxidative coupling to form disulfides.
  • Amine (–NH2): Enables amide formation with activated carboxyls (EDC/NHS, HATU) and urea/carbamate formation with isocyanates/carbonates when desired.
  • Carboxyl (–CO2H): Activation to NHS esters for onward coupling; formation of amide/ester linkages.

Retrosynthetic value:

  • As a terminal modifier to convert hydrophobic or poorly soluble species into water-compatible conjugates without altering core structure.
  • As a spacer to modulate sterics, binding, or surface accessibility in multivalent constructs, with PEG length dictating reach and hydration shell thickness.

Synthetic tips (literature):

  • Protecting groups: If orthogonal chemistry is needed, use thiol-protecting groups (Acm, Trt) or amine protections (Boc, Fmoc) in stepwise assembly; deprotect under conditions compatible with PEG stability.
  • Analytics: Monitor reactions by 1H NMR (mPEG CH3 ~3.35 ppm, –CH2–O– ~3.50–3.75 ppm), SEC for Mn shift, and colorimetric thiol assays. Note: Exact end-group protection/activation for this SKU is not specified; verify functional state on the CoA before planning syntheses.
Target Specificity

Not applicable to this product category. mPEG Cysteine is a chemical/polymeric reagent, not a biological targeting molecule or antibody. No antigen, epitope, clone, isotype, or species reactivity data are provided for this item.

Häufig gestellte Fragen

How should this product be stored?
Store at room temperature.
How is this product shipped?
This product ships under standard ambient conditions. No temperature-controlled packaging is required.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.